Cancer-Drug Shortages Targeted by Stopgap U.S. Approvals
Cancer-drug shortages that have plagued U.S. hospitals are being targeted by Food and Drug Administration decisions, announced today, giving generic-drug makers clearance to provide stopgap replacements.

FDA: New suppliers to ease 2 cancer drug shortages
TRENTON, N.J. Federal regulators have approved new suppliers for two crucial cancer drugs, easing critical shortages that had been ratcheting up fears that patients, particularly children with leukemia, would miss lifesaving treatments.